Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study

Jorge Rico Fontalvo, María Raad Sarabia, José C. De La Flor, Vicente Sánchez Polo, Jenniffer Benavides Garcia, Enrique Ramos Clason, Daniel Domínguez, Giovanny Mera Rebutti, Carlos Madrid Mancia, Rene Tabora López, Manuel Rocha Meza, Dany Tabora López, James J. Muñoz Zambrano, Eduardo Lorca Herrera, Eliana Dina-Batlle, Michael Cieza Terrones, Thyago Proença de Moraes, Tomas Rodríguez Yánez, Washington Osorio, Alyi Arellano Cabeza, Rodrigo Daza Arnedo

Open source

DOI
10.3390/medicina62071317
Published
2026-07-08
Container
Medicina
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62071317,
  title = {Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study},
  author = {Jorge Rico Fontalvo and María Raad Sarabia and José C. De La Flor and Vicente Sánchez Polo and Jenniffer Benavides Garcia and Enrique Ramos Clason and Daniel Domínguez and Giovanny Mera Rebutti and Carlos Madrid Mancia and Rene Tabora López and Manuel Rocha Meza and Dany Tabora López and James J. Muñoz Zambrano and Eduardo Lorca Herrera and Eliana Dina-Batlle and Michael Cieza Terrones and Thyago Proença de Moraes and Tomas Rodríguez Yánez and Washington Osorio and Alyi Arellano Cabeza and Rodrigo Daza Arnedo},
  year = {2026},
  journal = {Medicina},
  doi = {10.3390/medicina62071317},
  url = {https://doi.org/10.3390/medicina62071317}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study
AU  - Jorge Rico Fontalvo
AU  - María Raad Sarabia
AU  - José C. De La Flor
AU  - Vicente Sánchez Polo
AU  - Jenniffer Benavides Garcia
AU  - Enrique Ramos Clason
AU  - Daniel Domínguez
AU  - Giovanny Mera Rebutti
AU  - Carlos Madrid Mancia
AU  - Rene Tabora López
AU  - Manuel Rocha Meza
AU  - Dany Tabora López
AU  - James J. Muñoz Zambrano
AU  - Eduardo Lorca Herrera
AU  - Eliana Dina-Batlle
AU  - Michael Cieza Terrones
AU  - Thyago Proença de Moraes
AU  - Tomas Rodríguez Yánez
AU  - Washington Osorio
AU  - Alyi Arellano Cabeza
AU  - Rodrigo Daza Arnedo
PY  - 2026
JO  - Medicina
DO  - 10.3390/medicina62071317
UR  - https://doi.org/10.3390/medicina62071317
ER  - 

APA

Fontalvo, J. R., Sarabia, M. R., Flor, J. C. D. L., Polo, V. S., Garcia, J. B., Clason, E. R., Domínguez, D., Rebutti, G. M., Mancia, C. M., López, R. T., Meza, M. R., López, D. T., Zambrano, J. J. M., Herrera, E. L., Dina-Batlle, E., Terrones, M. C., Moraes, T. P. D., Yánez, T. R., Osorio, W., Cabeza, A. A., & Arnedo, R. D. (2026). Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study. Medicina. https://doi.org/10.3390/medicina62071317

Source records